131 related articles for article (PubMed ID: 32332870)
1. Management of conjunctival melanoma with local excision and adjuvant brachytherapy.
Brouwer NJ; Marinkovic M; Peters FP; Hulshof MCCM; Pieters BR; de Keizer RJW; Horeweg N; Laman MS; Bleeker JC; van Duinen SG; Jager MJ; Creutzberg CL; Luyten GPM
Eye (Lond); 2021 Feb; 35(2):490-498. PubMed ID: 32332870
[TBL] [Abstract][Full Text] [Related]
2. [Treatment modalities for conjunctival melanoma].
Krause L; Mladenova A; Bechrakis NE; Kreusel KM; Plath T; Moser L; Foerster M
Klin Monbl Augenheilkd; 2009 Dec; 226(12):1012-6. PubMed ID: 20108195
[TBL] [Abstract][Full Text] [Related]
3. [Recurrence rate following adjuvant strontium-90 brachytherapy after excision of conjunctival melanoma].
Krause L; Ritter C; Wachtlin J; Kreusel KM; Höcht S; Foerster MH; Bechrakis NE
Klin Monbl Augenheilkd; 2008 Jul; 225(7):649-52. PubMed ID: 18642208
[TBL] [Abstract][Full Text] [Related]
4. Conservative resection and adjuvant plaque brachytherapy for early-stage conjunctival melanoma.
Karim R; Conway RM
Clin Exp Ophthalmol; 2011; 39(4):293-8. PubMed ID: 21105970
[TBL] [Abstract][Full Text] [Related]
5. (106)Ru plaque brachytherapy for uveal melanoma: factors associated with local tumor recurrence.
Barker CA; Francis JH; Cohen GN; Marr BP; Wolden SL; McCormick B; Abramson DH
Brachytherapy; 2014; 13(6):584-90. PubMed ID: 24880583
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
7. Malignant melanoma of the eyelid and palpebral conjunctiva treated with iodine-125 brachytherapy.
Stannard CE; Sealy GR; Hering ER; Pereira SB; Knowles R; Hill JC
Ophthalmology; 2000 May; 107(5):951-8. PubMed ID: 10811089
[TBL] [Abstract][Full Text] [Related]
8. Histopathology-guided management of ocular surface squamous neoplasia with corneal stromal or scleral invasion using ruthenium-106 plaque brachytherapy.
Rao R; Honavar SG; Lahane S; Mulay K; Reddy VP
Br J Ophthalmol; 2023 May; 107(5):621-626. PubMed ID: 34844918
[TBL] [Abstract][Full Text] [Related]
9. Combined local excision and brachytherapy with ruthenium-106 in the treatment of epibulbar malignancies.
Zehetmayer M; Menapace R; Kulnig W
Ophthalmologica; 1993; 207(3):133-9. PubMed ID: 8278179
[TBL] [Abstract][Full Text] [Related]
10. Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study.
Jain P; Finger PT; Fili M; Damato B; Coupland SE; Heimann H; Kenawy N; J Brouwer N; Marinkovic M; Van Duinen SG; Caujolle JP; Maschi C; Seregard S; Pelayes D; Folgar M; Yousef YA; Krema H; Gallie B; Calle-Vasquez A;
Br J Ophthalmol; 2021 Oct; 105(10):1358-1364. PubMed ID: 32892167
[TBL] [Abstract][Full Text] [Related]
11. Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma.
Wuestemeyer H; Sauerwein W; Meller D; Chauvel P; Schueler A; Steuhl KP; Bornfeld N; Anastassiou G
Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):438-46. PubMed ID: 16133022
[TBL] [Abstract][Full Text] [Related]
12. Plaque radiotherapy in the management of scleral-invasive conjunctival squamous cell carcinoma: an analysis of 15 eyes.
Arepalli S; Kaliki S; Shields CL; Emrich J; Komarnicky L; Shields JA
JAMA Ophthalmol; 2014 Jun; 132(6):691-6. PubMed ID: 24557333
[TBL] [Abstract][Full Text] [Related]
13. Plaque brachytherapy for the management of ocular surface malignancies with corneoscleral invasion.
Walsh-Conway N; Conway RM
Clin Exp Ophthalmol; 2009 Aug; 37(6):577-83. PubMed ID: 19702707
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva.
Lommatzsch PK; Lommatzsch RE; Kirsch I; Fuhrmann P
Br J Ophthalmol; 1990 Oct; 74(10):615-9. PubMed ID: 2285686
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative high-dose rate of radioactive phosphorus 32 brachytherapy for diffuse recalcitrant conjunctival neoplasms: a retrospective case series and report of toxicity.
Marr BP; Abramson DH; Cohen GN; Williamson MJ; McCormick B; Barker CA
JAMA Ophthalmol; 2015 Mar; 133(3):283-9. PubMed ID: 25502420
[TBL] [Abstract][Full Text] [Related]
16. Conjunctival melanoma in the Netherlands: a nationwide study.
Missotten GS; Keijser S; De Keizer RJ; De Wolff-Rouendaal D
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):75-82. PubMed ID: 15623757
[TBL] [Abstract][Full Text] [Related]
17. Use of Ruthenium-106 Brachytherapy for Iris Melanoma: The Scottish Experience.
Agraval U; Sobti M; Russell HC; Lockington D; Ritchie D; Cauchi P; Kemp EG; Chadha V
Br J Ophthalmol; 2018 Jan; 102(1):74-78. PubMed ID: 28600302
[TBL] [Abstract][Full Text] [Related]
18. Local Failure After Episcleral Brachytherapy for Posterior Uveal Melanoma: Patterns, Risk Factors, and Management.
Bellerive C; Aziz HA; Bena J; Wilkinson A; Suh JH; Plesec T; Singh AD
Am J Ophthalmol; 2017 May; 177():9-16. PubMed ID: 28163118
[TBL] [Abstract][Full Text] [Related]
19. Repeat Episcleral Plaque Brachytherapy: Clinical Outcomes in Patients Treated for Locally Recurrent Posterior Uveal Melanoma.
King B; Morales-Tirado VM; Wynn HG; Gao BT; Ballo MT; Wilson MW
Am J Ophthalmol; 2017 Apr; 176():40-45. PubMed ID: 28048976
[TBL] [Abstract][Full Text] [Related]
20. Limbal stem cell transplantation: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2008; 8(7):1-58. PubMed ID: 23074512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
